1. HPV Type 16 Infection Switches Keratinocytes from Apoptotic to Proliferative Fate under TWEAK/Fn14 Interaction
   Hong Cheng et al, 2015, Journal of Investigative Dermatology CrossRef
2. Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney Disease
   M. Nusrat Sharif et al, 2016, PLOS ONE CrossRef
3. TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NFκB
   L Hénaut et al, 2016, Cell Death & Disease CrossRef
4. TWEAK/Fn14 axis in respiratory diseases
   Min Wang et al, 2020, Clinica Chimica Acta CrossRef
5. Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas
   Canan Güvenç et al, 2021, International Journal of Molecular Sciences CrossRef
6. IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1
   Emma Eriksson et al, 2019, The Journal of Immunology CrossRef
7. Biomeasures and mechanistic modeling highlight PK/PD risks for a monoclonal antibody targeting Fn14 in kidney disease
   Xiaoying Chen et al, 2018, mAbs CrossRef
8. TWEAK/Fn14 signaling in tumors
   Guanglei Hu et al, 2017, Tumor Biology CrossRef
9. Structural Basis and Targeting of the Interaction between Fibroblast Growth Factor-inducible 14 and Tumor Necrosis Factor-like Weak Inducer of Apoptosis
   Harshil Dhruv et al, 2013, Journal of Biological Chemistry CrossRef
10. Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer
    CEMIL BILIR et al, 2015, Oncology Letters CrossRef
11. Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
    Ole Audun Werner Haabeth et al, 2016, OncoImmunology CrossRef
12. Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer
    Ines Pombeiro et al, 2018, Journal of Clinical Medicine CrossRef
13. Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy
    Sidsel C. Lindgaard et al, 2022, Cancers CrossRef
14. Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy
    Olena Zaitseva et al, 2022, Frontiers in Pharmacology CrossRef
15. Microvesicles from indoxyl sulfate-treated endothelial cells induce vascular calcification in vitro
    Matilde Alique et al, 2020, Computational and Structural Biotechnology Journal CrossRef
16. Immunohistochemical expression of tumor necrosis factor‐like weak inducer of apoptosis and fibroblast growth factor‐inducible immediate early response protein 14 in oral squamous cell carcinoma and its implications
    Swetha Acharya et al, 2019, Journal of Investigative and Clinical Dentistry CrossRef
17. TWEAK/Fn14 Activation Participates in Skin Inflammation
    Qilu Liu et al, 2017, Mediators of Inflammation CrossRef
18. The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics
    J G Perez et al, 2016, Oncogene CrossRef
19. TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion
    Cheryl L. Armstrong et al, 2016, Oncotarget CrossRef